Arax Advisory Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $759K | Buy |
|
|||||
|
2025
Q1 | $293K | Buy |
|
|||||
|
2024
Q4 | $47.8K | Buy |
|
|||||
|
2024
Q3 | $38.2K | Sell |
|
|||||
|
2024
Q2 | $36.7K | Sell |
|
|||||
|
2024
Q1 | $111K | Buy |
|
|||||
|
2023
Q4 | $95.6K | Buy |
|
|||||
|
2023
Q3 | $89.8K | Buy |
|
|||||
|
2023
Q2 | $68.2K | Buy |
|
|||||
|
2023
Q1 | $38.8K | Buy |
|
|||||
|
2022
Q4 | $25.1K | Hold |
|
|||||
|
2022
Q3 | $21K | Buy |
|
|||||
|
2022
Q2 | $37K | Hold |
|
|||||
|
2022
Q1 | $37K | Sell |
|
|||||
|
2021
Q4 | $39K | Buy |
|
|||||
|
2021
Q3 | $32K | Buy |
|
|||||
|
2021
Q2 | $33K | Buy |
|
|||||
|
2020
Q4 | $30K | Hold |
|
|||||
|
2020
Q3 | $31K | Hold |
|
|||||
|
2020
Q2 | $34K | Buy |
|
|||||
|
2020
Q1 | $23K | Hold |
|
|||||
|
2019
Q4 | $28K | Hold |
|
|||||
|
2019
Q3 | $26K | Hold |
|
|||||
|
2019
Q2 | $24K | Buy |
|
|||||
|
2018
Q4 | $27K | Sell |
|
|||||
|
2018
Q3 | $39K | Sell |
|
|||||
|
2018
Q2 | $120K | Buy |
|
|||||
|
2018
Q1 | $112K | Buy |
|
|||||
|
2017
Q4 | $62K | Buy |
|
|||||
|
2017
Q3 | $67K | Sell |
|
|||||
|
2017
Q2 | $76K | Buy |
|
|||||
|
2017
Q1 | $74K | Buy |
|
|||||
|
2016
Q4 | $68K | Buy |
|